MacroGenics

MGNX • NASDAQ • Stock Fundamentals

MacroGenics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Blasius Risser, with a market cap of $284.1M.

Market Cap$284.1M

Employees339.0

CEOEric Blasius Risser

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about MacroGenics

MacroGenics (MGNX) has a market capitalization of $284.1M and trades on NASDAQ.

MacroGenics has approximately 339 employees.